Abstract:BackgroundResveratrol is a natural polyphenolic compound and its anticancer effect has been receiving considerable attention. Previous studies showed that resveratrol could inhibited the growth of human gastric carcinoma cells and apoptosis induction was an important mechanism. However, whether mitochondrial pathway was involved in resveratrol-induced apoptosis in human gastric cancer was not very clear. MethodsThe cells were examined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay, Annexin V/PI staining assay, mitochondrial membrane depolarization, cell morphological assessment, cytochrome c release assay, and Western blotting assay. ResultsIn this study, we found that resveratrol induced apoptosis in human gastric carcinoma SGC-7901 cells. Cleaved PARP was observed and caspase-3 was activated by resveratrol. Next, the mitochondrial membrane potential of cells dissipated after the cells were treated by resveratrol. Moreover, we found that pro-caspase 9 was downregulated and cytochrome c released from mitochondrial to the cytosol. We also found that the expression ratio of Bax/Bcl-2 was increased in the treated cells. We finally showed that resveratrol inhibited the proliferation of SGC-7901 xerograph in vivo. ConclusionsCollectively, our findings demonstrate that resveratrol triggers apoptosis via mitochondrial pathway in SGC-7901 cells, which provide more basis for resveratrol acting as antitumor agents in cancer therapy.

Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells

Myricetin Inhibits Proliferation of Cisplatin-Resistant Cancer Cells Through a P53-Dependent Apoptotic Pathway

Myricetin Induces Apoptosis In Hepg2 Cells Through Akt/P70s6k/Bad Signaling And Mitochondrial Apoptotic Pathway

Myricetin Induces Protective Autophagy by Inhibiting the Phosphorylation of Mtor in HepG2 Cells

Myricetin Induces Apoptosis and Protective Autophagy through Endoplasmic Reticulum Stress in Hepatocellular Carcinoma

Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex.

Inhibition effects and induction of apoptosis of flavonoids on the prostate cancer cell line PC-3 in vitro

Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway

Myricetin Protects Cells against Oxidative Stress-Induced Apoptosis via Regulation of PI3K/Akt and MAPK Signaling Pathways

Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells.

Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells

Myricetin: versatile plant based flavonoid for cancer treatment by inducing cell cycle arrest and ROS–reliant mitochondria-facilitated apoptosis in A549 lung cancer cells and in silico prediction

Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress

INHIBITION OF MYRICETIN ON HUMAN LUNG ADENOCARCINOMA H460 CELL PROLIFERATION AND THE ROLE OF ERK PATHWAY

Myricetin: targeting signaling networks in cancer and its implication in chemotherapy

Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells

Resveratrol Induced Apoptosis in Human Gastric Carcinoma SGC‐7901 Cells Via Activation of Mitochondrial Pathway

Flavonoids Inhibit Cell Proliferation And Induce Apoptosis And Autophagy Through Downregulation Of Pi3k Gamma Mediated Pi3k/Akt/Mtor/P70s6k/Ulk Signaling Pathway In Human Breast Cancer Cells

Myricetin reverses epithelial–endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1

Mollugin Induces Tumor Cell Apoptosis and Autophagy Via the Pi3k/Akt/Mtor/P70s6k and Erk Signaling Pathways

Myricetin Protects Against Diet-Induced Obesity and Ameliorates Oxidative Stress in C57BL/6 Mice